GlassScriptPhysician profile
Mollie Baker
NPI 1326510702
$829.71
in general payments reported to CMS, 2019-2025
10 companies · $172 in 2025
The $172 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $69.30 · 2023: $367 · 2024: $221 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $760.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $117.13 | 2025 | Descovy |
| Astrazeneca Pharmaceuticals LP | $106.67 | 2023 | Andexxa |
| Insmed, INC. | $100.80 | 2023 | Arikayce |
| Amgen INC. | $95.40 | 2024 | Repatha |
| Boston Scientific Corporation | $93.44 | 2024 | Eluvia |
| Kci USA, INC. | $89.39 | 2023 | Prevena |
| Abbott Laboratories | $70.36 | 2023 | Xience Sierra, Nc Trek Neo, Xience Skypoint |
| Urovant Sciences INC | $69.30 | 2022 | |
| Coloplast Corp | $54.69 | 2025 | |
| Merck Sharp & Dohme LLC | $32.53 | 2024 | Lynparza, Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mollie Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.